Tumour necrosis factor-α expression in idiopathic dilated cardiomyopathy: Correlation to myocardial inflammatory activity

Cytokine

Volumn 12, Issue 8, 2000, Pages 1261-1266

  Sigusch, Holger H ^a   Lehmann, Michael H ^a   Schnittler, Uta ^a   Reinhardt, Dirk ^a   Figulla, Hans R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Heart failure; Idiopathic dilated cardiomyopathy; Myocarditis; Tumour necrosis factor alpha

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FEMALE; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MYOCARDITIS; PRIORITY JOURNAL;

EID: 0033865779     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0705     Document Type: Article

References (9)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241.
2. Torre Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711.
3. Torre Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. 92:1995;1487-1493.
4. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 81:1997;627-635.
5. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation. 97:1998;1375-1381.
6. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. J Clin Invest. 76:1985;1539-1553.
7. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 318:1988;1481-1486.
8. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies [news] [see comments]. Circulation. 93:1996;841-842.
9. Lehmann MH, Kühnert H, Müller S, Sigusch HH. Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy. Cytokine. 10:1998;739-746.